VELARDI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 5.193
EU - Europa 4.290
AS - Asia 3.362
SA - Sud America 596
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 13.508
Nazione #
US - Stati Uniti d'America 5.101
SG - Singapore 1.503
IE - Irlanda 780
IT - Italia 732
UA - Ucraina 619
SE - Svezia 590
HK - Hong Kong 565
CN - Cina 544
BR - Brasile 512
RU - Federazione Russa 433
VN - Vietnam 354
FI - Finlandia 316
DE - Germania 297
KR - Corea 164
GB - Regno Unito 161
FR - Francia 82
CA - Canada 48
IN - India 44
TR - Turchia 44
CH - Svizzera 39
PL - Polonia 37
AT - Austria 36
NL - Olanda 36
AR - Argentina 34
BE - Belgio 32
MX - Messico 31
ZA - Sudafrica 29
CZ - Repubblica Ceca 26
BD - Bangladesh 25
RO - Romania 23
IQ - Iraq 22
UZ - Uzbekistan 19
JP - Giappone 18
GR - Grecia 15
EC - Ecuador 13
LT - Lituania 10
CO - Colombia 9
ES - Italia 8
LB - Libano 8
CL - Cile 6
ID - Indonesia 6
PE - Perù 6
PK - Pakistan 6
VE - Venezuela 6
IL - Israele 5
PH - Filippine 5
PY - Paraguay 5
BG - Bulgaria 4
EG - Egitto 4
EU - Europa 4
AZ - Azerbaigian 3
BO - Bolivia 3
JO - Giordania 3
KE - Kenya 3
LV - Lettonia 3
MA - Marocco 3
OM - Oman 3
SA - Arabia Saudita 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CI - Costa d'Avorio 2
CM - Camerun 2
DK - Danimarca 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
KZ - Kazakistan 2
MK - Macedonia 2
ML - Mali 2
MY - Malesia 2
PT - Portogallo 2
TJ - Tagikistan 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DJ - Gibuti 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MG - Madagascar 1
NG - Nigeria 1
NR - Nauru 1
PS - Palestinian Territory 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 13.502
Città #
Singapore 978
Dublin 780
Chandler 741
San Mateo 604
Hong Kong 563
Jacksonville 324
Boardman 318
Perugia 286
Ashburn 263
Santa Clara 224
Dong Ket 178
Medford 176
Princeton 175
Altamura 168
Seoul 159
Beijing 154
Ann Arbor 147
Moscow 137
Wilmington 137
Lawrence 127
Andover 120
Munich 98
Helsinki 92
Los Angeles 81
New York 72
Ho Chi Minh City 68
Piscataway 68
Turku 64
Saint Petersburg 49
Des Moines 48
Norwalk 47
São Paulo 45
Shanghai 35
Hanoi 34
The Dalles 33
Woodbridge 32
Brussels 27
San Paolo di Civitate 26
Brooklyn 25
Frankfurt am Main 25
Houston 25
Izmir 25
Redmond 25
Dallas 21
London 21
Warsaw 21
Johannesburg 20
Falls Church 19
Rome 19
Stockholm 19
Boston 18
Brno 18
Bucharest 18
Rio de Janeiro 18
San Francisco 18
Atlanta 17
Chicago 17
Hefei 17
Nuremberg 17
Tokyo 17
Amsterdam 16
Dearborn 16
Montreal 16
Falkenstein 15
Phoenix 15
Vienna 15
Belo Horizonte 14
Auburn Hills 13
Bologna 13
Espoo 13
Foligno 13
Guangzhou 13
Chennai 12
Columbus 12
Denver 12
Florence 12
Milan 12
Redwood City 12
Prata Di Pordenone 11
Brasília 10
Manchester 10
Groningen 9
Seattle 9
Sorocaba 9
Tianjin 9
Toronto 9
Da Nang 8
Den Haag 8
Orem 8
Poplar 8
Terni 8
West Jordan 8
Can Tho 7
Changsha 7
Erbil 7
Padova 7
Baghdad 6
Bexley 6
Biên Hòa 6
Campinas 6
Totale 8.538
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 160
Innate immunity against hematological malignancies 134
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 129
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells 125
14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation. 119
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 116
Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk 111
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 110
Fourth international workshop on haploidentical transplants, Naples, Italy 109
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 108
TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation 108
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 107
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 107
T helper 2 antagonists restore antifungal T helper immunity in mice with T cell-depleted bone marrow transplantation 105
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 104
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 104
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 101
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 100
"Designed" grafts for HLA-haploidentical stem cell transplantation. 99
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 99
A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation 99
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 98
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 98
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 97
Transplants across human leukocyte antigen barriers 96
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 96
The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism 96
Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1. 96
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 95
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 93
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. 93
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 92
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 91
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 91
Increased Ratio of CD31+/CD42- Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholesterolemia. 91
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 91
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 91
Allogeneic transplantation across the HLA barriers. 91
Haploidentical stem cell transplantation for acute leukemia 89
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 89
Allogenic and autologous transplantation for haematological diseases, solid tumours and immune disorders:current practice in europe 2009. 89
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 89
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors 88
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 88
CMV management with specific immunoglobulins: A multicentric retrospective analysis on 92 allotransplanted patients 88
Natural killer cells: biology and application in stem-cell transplantation 87
Non-MHC-restricted cytotoxic cells: Their roles in the control and treatment of leukaemias 87
The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation. . 87
16th IHIW: international histocompatibility working group in hematopoietic cell transplantation. 87
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 87
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 86
Natural killer cell alloreactivity for leukemia therapy. 86
. Mismatched hematopoietic stem cell transplants in elderly patients. 86
Cellular therapy: exploiting NK cell alloreactivity in transplantation 85
Preclinical characterization of 1-7F9,a novel human anti-KIR receptor therapeutic antibody that augments natural kille-mediated killing of tumor cells. 85
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 85
The effect of TNF-α on regulatory T cell function in graft-versus-host disease 85
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation 85
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 83
Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation 83
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 83
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 83
Mismatched hematopoietic stem cell transplantation in secondary leukemia 82
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. 82
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 82
Total Marrow/Total Lymphoid Irradiation as Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients 81
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 81
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 80
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 80
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 80
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 80
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 80
Haploidentical transplantation and natural killer cell recognition of missing self. 79
NCRs and DNAM-1 mediate NK cell recognition and iysis of human and mouse melanoma cell lines in vitro and in vivo 79
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells. 78
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 78
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation 78
TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 78
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 77
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants 76
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants 76
Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation 76
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. 76
Deploying natural killer cell allotherapy in the setting of HLA-haplotype-mismatched hematopoietic stem cell transplantation 76
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 75
Natural killer cell-mediated lysis of autologous cells modified by gene therapy 74
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 74
T cells expressing chimeric antigen receptor promote immune tolerance 74
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. 74
New mechanism of lymphoma-induced bone marrow aplasia 74
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. 73
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 73
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 72
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 72
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 72
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: A retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation 72
Full haplotype mismatched transplant in high risk acute leukemia patients. 71
Post-grafting granulocyte colony-stimulating factor administration impairs functional immune recovery in recipients of HLA haplotype-mismatched hematopoietic transplants 71
Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia 70
Defective antifungal immunity in a murine model of allogeneic T-cell depleted bone marrow transplantation: Restoration by cytokine/cytokine antagonist treatment 69
Totale 8.915
Categoria #
all - tutte 66.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.310


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021750 0 0 0 0 0 93 100 8 155 59 132 203
2021/20221.820 34 486 63 120 77 13 24 491 9 53 230 220
2022/20232.542 193 498 21 188 177 257 5 115 957 10 94 27
2023/20241.124 58 120 43 20 7 19 240 21 120 31 198 247
2024/20252.628 57 270 87 128 362 88 73 187 492 151 488 245
2025/20262.807 407 367 328 733 777 195 0 0 0 0 0 0
Totale 13.922